CD274 and hepatocellular carcinoma: Further, we observed that late-stage HCC patients (TNM IV, pathology grading 3) maintained higher levels of PD-L1 compared with those of early stage HCC patients (TNM I, pathology grading 1) (Supplementary Table 4).